PRRT2 and Behcet disease: In addition, tamoxifen, a drug approved to prevent and treat breast cancer, is a CNS-penetrant PKC inhibitor with demonstrated efficacy in acute manic or mixed episodes of BD, both adjunctively and as monotherapy (Zarate et al., 2007; Yildiz et al., 2008; Saxena et al., 2017).